We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $398M
1-Year Est. Return 22.87%
This Fund
S&P 500
This Quarter Est. Return
+1.4%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$427M
AUM Growth
+$34.6M
Cap. Flow
+$33M
Cap. Flow %
7.75%
Top 10 Hldgs %
42.72%
Holding
188
New
25
Increased
60
Reduced
24
Closed
4

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$3.71M
2
AAPL icon
Apple
AAPL
+$3.22M
3
AMGN icon
Amgen
AMGN
+$2.12M
4
LLY icon
Eli Lilly
LLY
+$2M
5
TXN icon
Texas Instruments
TXN
+$1.82M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$1.36M
2
NKE icon
Nike
NKE
+$865K
3
INCY icon
Incyte
INCY
+$413K
4
BAC icon
Bank of America
BAC
+$337K
5
HRTX icon
Heron Therapeutics
HRTX
+$231K

Sector Composition

Rank Sector Weight
1 Financials 23.49%
2 Technology 18.61%
3 Healthcare 13.85%
4 Industrials 10.48%
5 Consumer Staples 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEO
176
Adams Natural Resources Fund
PEO
$722M
$201K 0.05%
+8,831
New +$198K
NOK icon
177
Nokia
NOK
$56.5B
$107K 0.03%
+28,223
New +$104K
WOOF icon
178
Petco
WOOF
$760M
$75.6K 0.02%
+20,000
New +$51.1K
PLBY icon
179
Playboy Inc
PLBY
$135M
$62.6K 0.01%
80,502
+8,249
+11% +$7.67K
ABCL icon
180
AbCellera Biologics
ABCL
$1.97B
$44.4K 0.01%
15,000
+1,100
+8% +$4.16K
HRTX icon
181
Heron Therapeutics
HRTX
$89.1M
$38.5K 0.01%
11,000
-75,250
-87% -$231K
TMC icon
182
TMC The Metals Company
TMC
$1.62B
$13.5K ﹤0.01%
10,000
VGZ icon
183
Vista Gold
VGZ
$225M
$12.6K ﹤0.01%
27,000
MLSS icon
184
Milestone Scientific
MLSS
$38.7M
$6.83K ﹤0.01%
+10,000
New +$6.65K
BAX icon
185
Baxter International
BAX
$11.7B
-31,752
Closed -$1.36M
INCY icon
186
Incyte
INCY
$23.4B
-7,250
Closed -$413K
REAL icon
187
The RealReal
REAL
$1.35B
-10,000
Closed -$39.1K
SA
188
Seabridge Gold
SA
$2.65B
-13,500
Closed -$204K

Similar funds

Searle & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Searle & Co held 188 positions worth $427M, up 8.8% from $392M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Searle & Co deployed $33M of net new capital in Q2 2024, opening 25 new positions and adding to 60 existing holdings. Its largest new stake was Amgen: 7,221 shares worth $2.26M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Nike, an estimated $865K trimmed.

  • Searle & Co's largest Q2 2024 buy was Amgen: 7,221 shares worth $2.26M.
  • Searle & Co added most to JPMorgan Chase in Q2 2024, an estimated $3.71M increase.
  • Searle & Co's biggest Q2 2024 reduction was Nike, cutting an estimated $865K.
  • Searle & Co fully exited Baxter International in Q2 2024, selling an estimated $1.36M.
  • Searle & Co's ten largest holdings make up 43% of its $427M portfolio in Q2 2024.
  • Searle & Co opened 25 new positions and closed 4 in Q2 2024.
  • Searle & Co's portfolio value rose 8.8% quarter-over-quarter to $427M.

Based on Searle & Co's 13F filing for Q2 2024, filed 30 Jul 2024.